In general, AIBDs are typically described as targeting a single antigen, with autoantibodies to secondary antigens acquired via epitope spreading, i.e., desmoglein 1 (Dsg1) in mucocutaneous-type pemphigus vulgaris (PV) or BP230 in BP [25,26]. This evidence concerns the gene DST and acquired polycythemia vera.